1910 Genetics

Cambridge, MA

1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.